End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.7 SEK | +1.09% | -.--% | +4.14% |
Mar. 01 | Royal Philips Partners SyntheticMR to Roll Out New Brain Disorder Diagnosis Technology | MT |
Feb. 20 | SyntheticMR AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2023 | 89.21M 8.37M | Sales 2024 * | 112M 10.51M | Capitalization | 1.15B 108M |
---|---|---|---|---|---|
Net income 2023 | 10M 938K | Net income 2024 * | 22M 2.06M | EV / Sales 2023 | 12.2 x |
Net cash position 2023 | 21.32M 2M | Net cash position 2024 * | 28.42M 2.67M | EV / Sales 2024 * | 10.1 x |
P/E ratio 2023 |
116
x | P/E ratio 2024 * |
50.5
x | Employees | 40 |
Yield 2023 * |
0.54% | Yield 2024 * |
0.72% | Free-Float | 53.27% |
1 day | +1.09% | ||
3 months | +2.21% | ||
6 months | +20.43% | ||
Current year | +4.14% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Harrysson
CEO | Chief Executive Officer | 55 | 19-08-31 |
Founder | 51 | 07-02-15 | |
Kyle Frye
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 12-12-31 | |
Director/Board Member | 60 | - | |
Founder | 51 | 07-02-15 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.14% | 109M | |
+21.23% | 37.65B | |
+8.26% | 6.99B | |
+14.56% | 3.74B | |
-0.91% | 3.73B | |
-27.35% | 1.27B | |
-22.30% | 1.34B | |
-32.52% | 944M | |
-25.64% | 846M | |
-7.60% | 826M |